Compounded Tirzepatide Dosage Calculator
Calculate appropriate compounded tirzepatide dosages, titration schedules, and treatment requirements based on patient-specific factors and clinical guidelines.
How to Use This Calculator
- Enter the patient's weight in kilograms
- Specify the starting, current, and target tirzepatide doses
- Input the concentration of the compounded medication
- Set the titration interval and treatment duration
- Click Calculate to view the dosage schedule and treatment plan
Formula Used
Volume (mL) = Dose (mg) ÷ Concentration (mg/mL)
Where:
- Volume = Amount of medication to administer
- Dose = Prescribed tirzepatide amount
- Concentration = Strength of compounded medication
Example Calculation
Real-World Scenario:
A patient weighing 85 kg is starting tirzepatide for weight management. The compounded medication has a concentration of 5 mg/mL, with a starting dose of 2.5 mg and target dose of 15 mg.
Given:
- Patient Weight = 85 kg
- Starting Dose = 2.5 mg
- Target Dose = 15 mg
- Concentration = 5 mg/mL
Calculation:
Starting Volume = 2.5 mg ÷ 5 mg/mL = 0.5 mL
Target Volume = 15 mg ÷ 5 mg/mL = 3.0 mL
Result: The patient will start with 0.5 mL weekly and titrate up to 3.0 mL weekly over approximately 28 weeks.
Why This Calculation Matters
Practical Applications
- Ensures accurate dosing for compounded medications
- Helps plan medication supply for treatment duration
- Provides clear titration schedule for patients
Key Benefits
- Reduces dosing errors with compounded medications
- Optimizes treatment outcomes with proper titration
- Helps estimate medication costs and supply needs
Common Mistakes & Tips
Frequently Asked Questions
References & Disclaimer
Medical Disclaimer
This calculator is for informational purposes only and does not constitute medical advice. Always consult with a healthcare provider before starting or adjusting any medication. The dosage calculations provided should be verified by a qualified medical professional.
References
- Tirzepatide Once Weekly for the Treatment of Obesity - SURMOUNT-1 Trial Results
- Tirzepatide for Type 2 Diabetes - SURPASS Program Clinical Trials
- FDA Warning on Compounded GLP-1 Medications - FDA Safety Communication
Accuracy Notice
This calculator provides estimates based on standard dosing protocols. Individual patient needs may vary based on medical history, concurrent medications, and response to treatment. The calculations should be used as a starting point for clinical decision-making, not as a substitute for professional medical judgment.
About the Author
Kumaravel Madhavan
Web developer and data researcher creating accurate, easy-to-use calculators across health, finance, education, and construction and more. Works with subject-matter experts to ensure formulas meet trusted standards like WHO, NIH, and ISO.